A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

The collaboration includes the initial validation and deployment of Ibex Prostate within HNL Lab Medicine’s LDT workflow.

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...

But does it cost too much?

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of ...

Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...